U.S. temporary duty-free treatment of infant formula base powder
Limited to certain infant formula base powder exported to the United States on or before November 14, 2022
Infant formula base powder exported to the United States on or before November 14, 2022
U.S. Customs and Border Protection (CBP) today issued a release announcing that it will provide duty-free treatment of eligible infant formula base powder entered or withdrawn from warehouse for consumption on or after October 13, 2022, through December 31, 2022.
Today’s CBP guidance—CSMS # 53599807—explains that the duty-free treatment:
- Will only be provided to importers of base powder to be manufactured into infant formula authorized to be marketed in the United States or subject to an enforcement discretion letter from the Food and Drug Administration (FDA)
- Is limited to certain infant formula base powder classifiable under Harmonized Tariff Schedule (HTS) subheading 1901.90.62 exported to the United States on or before November 14, 2022
Background
The president on October 10, 2022, signed into law H.R. 8982, the “Bulk Infant Formula to Retail Shelves Act,” which temporarily suspends duty on imports of certain infant formula base powder.
The Office of Trade (OT) updated the HTS file in the Automated Commercial Environment (ACE) to account for the law.
For more information, contact a professional with KPMG’s Trade & Customs services:
Doug Zuvich |
John L. McLoughlin |
Andy Siciliano |
Steve Brotherton |
Luis (Lou) Abad |
Irina Vaysfeld |
Amie Ahanchian |
Christopher Young |
Gisele Belotto |
George Zaharatos |
Andy Doornaert |
Jessica Libby Principal E: jlibby@kpmg.com |
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 3712, 1801 K Street NW, Washington, DC 20006.